Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-16

Clinical Trial Update: fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluated fMRI-guided transcranial magnetic stimulation as a treatment for Parkinson's disease. The sponsor is Changping Laboratory.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changping Laboratory | Conditions: Parkinson's Disease | NA | Status: COMPLETED